Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021

SIMPLE SUMMARY: In operated pancreatic cancer patients who are able to begin treatment within 3 months after surgery, adjuvant chemotherapy is currently used to limit disease recurrence but questions remain for the clinician. Recently, modified FOLFIRINOX has become the standard-of-care in the non-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Turpin, Anthony, el Amrani, Mehdi, Bachet, Jean-Baptiste, Pietrasz, Daniel, Schwarz, Lilian, Hammel, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767489/
https://www.ncbi.nlm.nih.gov/pubmed/33371464
http://dx.doi.org/10.3390/cancers12123866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767489/
https://www.ncbi.nlm.nih.gov/pubmed/33371464
http://dx.doi.org/10.3390/cancers12123866

Ejemplares similares